The Lancet "Global Health Report"

Global Health 2050

“Global Health 2050” published by the The Lancet Commission on Investing in Health asserts that it’s feasible to  reduce premature mortality by 50% by 2050.

Headshot of John S. Evans top left and Lisa Robinson bottom right.

New “Risk and Decisions” Course

John S. Evans and CHDS' Lisa A. Robinson will co-lead the the course Environmental Risk Assessment and Policy (EH 550) beginning January 2025.

FACULTY SPOTLIGHT
Soroush Saghafian headshot

Saghafian’s Lab Receives Award

CHDS’ Soroush Saghafian with others received a Department of Defense grant to use AI to optimize melanoma treatment through genomic data analysis.

Recent News

CHDS at International HPV Meeting in Scotland

January 7th, 2025

The CHDS Cervical Cancer Team, including Nicole Campos, Jenny Spencer, Emily Burger, and Allison Portnoy, and led by CHDS faculty Jane Kim, presented their latest research findings

Read more...

“One Screen” Cervical Cancer Control

December 6th, 2024

CHDS faculty Nicole Campos and a team of researchers at the National Cancer Institute (NCI), including Principal Deputy Director of the NCI Douglas Lowy, Senior Investigator Mark Schiffman, and

Read more...

New “Risk and Decisions” Course

December 4th, 2024

Determining whether and how to control environmental hazards raises many challenging questions related to understanding the risks and the benefits and costs of controls. In this new

Read more...

CHDS at INFORMS 2024

November 21st, 2024

Doctoral students Jacob Jameson, Skye Yoden, and Yu Li (Lily) Hsieh presented at the 2024 INFORMS Annual Meeting held in Seattle in October. Hosted by the Institute

Read more...